Incontinence Pads and UTI Risk
While Poise incontinence pads themselves do not directly cause UTIs, the underlying urinary incontinence and pad use are both independently associated with increased UTI risk in women. The relationship is complex: incontinence creates a moist perineal environment that facilitates bacterial colonization, and pad use is a marker for this underlying risk rather than a direct causative agent 1.
Understanding the Association
The evidence shows that postmenopausal women are at increased risk for recurrent UTI in the presence of urinary incontinence, independent of the management method 1. This occurs because:
- UTIs develop when normal periurethral flora are replaced by uropathogenic bacteria that ascend into the bladder 1
- Urinary incontinence itself characterizes women who experience UTIs, both during infection-free periods and acute episodes 2
- Women with incontinence who use pads have higher baseline rates of urine loss compared to continent women 2
Evidence on Pad Use and UTI Risk
Research demonstrates a clear association between pad use and UTI development:
- Full-time pad users have twice the odds of being admitted with UTI (OR=2.00,95% CI: 1.61-2.49) 3
- Nursing home residents using absorbent pads show significantly higher UTI rates (41% vs 11% in non-users) 4
- Among reproductive-age women, daily pad use is a significant risk factor for UTI (OR 1.92,95% CI 1.03-3.57) 5
However, the number of pad changes per day does not correlate with UTI risk 4, suggesting the association relates to the underlying incontinence severity rather than pad hygiene practices specifically.
Clinical Implications and Management
Primary Prevention Strategies
Rather than focusing on the pad product itself, address modifiable risk factors 1, 6:
- First-line: Pelvic floor muscle training for stress incontinence (strong recommendation)
- Bladder training for urgency incontinence
- Weight loss and exercise for obese women with incontinence
- Ensure adequate hydration to promote frequent urination
- Encourage urge-initiated voiding and post-coital voiding
- For postmenopausal women: consider topical vaginal estrogen 7
When UTIs Become Recurrent
If a woman develops ≥3 UTIs in 12 months despite behavioral measures 1:
Non-antibiotic options first:
Antibiotic prophylaxis only after non-antimicrobial measures fail:
- Continuous: TMP-SMX 40/200mg daily or nitrofurantoin 50-100mg daily
- Post-coital: TMP-SMX 40/200mg or nitrofurantoin 50-100mg once after intercourse 8
Important Caveats
The pad brand (Poise or otherwise) is not the issue—one case report of contact dermatitis to pad materials exists 9, but this is unrelated to UTI risk. The critical factor is the underlying incontinence creating a warm, moist environment conducive to bacterial growth.
Women often change pads for reasons unrelated to saturation (median saturation at change is only 9.5% of capacity), typically to fit daily routines 10. This "overuse" doesn't increase UTI risk but represents unnecessary expense and waste.
Bottom line: Counsel patients that managing their incontinence through behavioral and physical therapy interventions will reduce both pad dependence and UTI risk more effectively than changing pad brands or frequency.